FIELD: medicine.
SUBSTANCE: method of diagnostics of vascular calcification of cardiovascular system in patients with coronary heart disease consists of the following stages: getting a blood sample of a patient with coronary heart disease (CHD); measurement of gene products mir-199a-5p and mir-382 in blood samples of the patient with coronary heart disease using the methods of estimating the amount of RNA; comparison of the level of production of genes mir-199a-5p and mir-382 in tested samples with control; prediction of the existence of calcification in patients with coronary heart disease, if the level of production of genes mir-199a-5p and mir-382 in tested samples is increased compared with control samples.
EFFECT: improved diagnostic accuracy.
1 tbl, 3 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| RECOMBINANT PLASMID DNA CODING microRNA hsa-miR-143-5p, AND ITS USE AS POSITIVE CONTROL IN REAL-TIME PCR FOR DIAGNOSING CARDIOVASCULAR DISEASES AND DETECTING RISK OF THEIR DEVELOPMENT | 2025 |
|
RU2837872C1 |
| RECOMBINANT PLASMID DNA CODING microRNA hsa-miR-143-3p, AND ITS USE AS POSITIVE CONTROL IN REAL-TIME PCR FOR DIAGNOSING CARDIOVASCULAR DISEASES AND DETECTING RISK OF THEIR DEVELOPMENT | 2025 |
|
RU2837882C1 |
| RECOMBINANT PLASMID DNA CODING microRNA hsa-miR-145-5p, AND ITS USE AS POSITIVE CONTROL IN REAL-TIME PCR FOR DIAGNOSING CARDIOVASCULAR DISEASES AND DETECTING RISK OF THEIR DEVELOPMENT | 2025 |
|
RU2837874C1 |
| SET OF OLIGODEOXYRIBONUCLEOTIDE PRIMERS FOR DIAGNOSING CARDIOVASCULAR DISEASES AND DETECTING RISK OF THEIR DEVELOPMENT BASED ON BIOMOLECULAR MARKER microRNA hsa-miR-143-5p BY QUANTITATIVE PCR AND USE THEREOF | 2025 |
|
RU2838258C1 |
| SET OF OLIGODEOXYRIBONUCLEOTIDE PRIMERS FOR DIAGNOSING CARDIOVASCULAR DISEASES AND DETECTING RISK OF THEIR DEVELOPMENT BASED ON BIOMOLECULAR MARKER microRNA hsa-miR-143-3p BY QUANTITATIVE PCR AND USE THEREOF | 2025 |
|
RU2838257C1 |
| RECOMBINANT PLASMID DNA CODING microRNA hsa-miR-145-3p, AND ITS USE AS POSITIVE CONTROL IN REAL-TIME PCR FOR DIAGNOSING CARDIOVASCULAR DISEASES AND DETECTING RISK OF THEIR DEVELOPMENT | 2025 |
|
RU2837873C1 |
| METHODS FOR PATHOLOGICAL CHANGES DETECTION IN ORGAN OR SYSTEM OF ORGANS | 2012 |
|
RU2626540C2 |
| METHOD FOR PREDICTING COMPLICATIONS IN PATIENTS WITH CHRONIC HEART FAILURE AFTER CARDIAC SURGERIES WITH ARTIFICIAL CIRCULATION | 2017 |
|
RU2680602C1 |
| SET OF OLIGODEOXYRIBONUCLEOTIDE PRIMERS FOR DIAGNOSING CARDIOVASCULAR DISEASES AND DETECTING RISK OF THEIR DEVELOPMENT BASED ON BIOMOLECULAR MARKER microRNA hsa-miR-145-3p BY QUANTITATIVE PCR AND USE THEREOF | 2025 |
|
RU2838260C1 |
| METHOD FOR DETERMINING RISK OF AORTIC VALVE CALCIFICATION IN PATIENTS 60 YEARS OF AGE AND OLDER | 2020 |
|
RU2754946C1 |
